Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized trial of concomitant radiotherapy with cisplatin in head and neck squamous cell carcinoma
2015-001928-29Phase 2Completed
- Sponsor
- GORTEC
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of cisplatin in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by GORTEC. Started Jul 2015; status: completed.
02
Drugs
cisplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on 2015-001928-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001928-29.